shutterstock_298303490_vonaua
VonaUA / Shutterstock.com
24 March 2020AfricaSarah Morgan

US companies hit hardest by fake medicines: EUIPO, OECD

Companies registered in the US are hit hardest by the trade in counterfeit medicines, which in 2016 reached $4.4 billion, according to a report from the  European Union Intellectual Property Office (EUIPO).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
20 December 2022   Operation took place across Europe | Criminal networks are still exploiting opportunities offered by the COVID-19 pandemic.
Big Pharma
1 May 2020   Once a genuine vaccine against COVID-19 has been announced, counterfeiters and fraudsters are likely to invest heavily in offering ineffective counterfeit versions of the vaccine online, according to Europol.
Big Pharma
22 April 2020   The COVID-19 pandemic is heightening the dangers posed by the global trade in counterfeit pharmaceutical products, according to the OECD and EUIPO.